Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Karin Thompson
Lysophosphatidic Acid Type 2 Receptor Agonists in Targeted Drug Development Offer Broad Therapeutic Potential
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
Efficiency of the SIRS and MMPI-2 Validity Scales to Detect Over Reporting in PTSD Evaluations
Related publications
Targeted Lysophosphatidic Acid Receptor Antagonists for Hepatocellular Carcinoma Chemoprevention
HPB
Hepatology
Gastroenterology
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Lysophosphatidic Acid Receptor 1 (LPAR1; EDG2; LPA1)
Science-Business eXchange
Tumor Necrosis Factor Receptor 2: A Potential Target for Antidepressant Drug Development
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Neurobiology of the Edg2 Lysophosphatidic Acid Receptor.
The Japanese Journal of Pharmacology
Polyunsaturated Lysophosphatidic Acid as a Potential Asthma Biomarker
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Therapeutic Applications of TRAIL Receptor Agonists in Cancer and Beyond
Pharmacology and Therapeutics
Pharmacology
Characterization of a Receptor Subtype-Selective Lysophosphatidic Acid Mimetic
Molecular Pharmacology
Molecular Medicine
Pharmacology
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology